562164

BioReliance Corporation — FEI 1122041

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 18, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)